Peter Barrett
Atlas Venture Partner
investment range
$500k - $5.0m
sweet spot
$2.0m
Peter Barrett's Past Investments (20)
| Company | Deal Type | Amount | Date | |
|---|---|---|---|---|
| Obsidian Therapeutics | Series A | $49.5M | Dec 2017 | |
| Indalo Therapeutics | Venture Round | $9M | Aug 2017 | |
| Synlogic | Series C | $42M | May 2017 | |
| DeepScale | Seed Round | $3M | Mar 2017 | |
| JenaValve Technology | Series C | $26.5M | Aug 2015 | |
| Raze Therapeutics | Series A | $24M (Lead) | Oct 2014 | |
| Synlogic | Series A | $29.4M (Lead) | Jul 2014 | |
| JenaValve Technology | Series C | $10M | Apr 2014 | |
| Harbour Antibodies | Series A | €2.5M (Lead) | Jul 2013 | |
| JenaValve Technology | Series C | $62.5M | Jul 2013 |
Peter Barrett's Media
No media found for Peter Barrett.